1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6B9C123EBF55472F085257C1B005541B0
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/competitive-intelligence-structure-reporting-evolution-and-best-practices?opendocument
18
19opendocument
2018.232.53.231
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Competitive and Business Intelligence Strategic Insights

Competitive Intelligence Excellence: Structure, Reporting, CI Evolution and Best Practices

ID: 5277


Features:

21 Info Graphics

10 Data Graphics

120+ Metrics

19 Narratives


Pages/Slides: 38


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Competitive Intelligence Excellence: Structure, Reporting, CI Evolution and Best Practices."


STUDY OVERVIEW

When done well, the Competitive Intelligence (CI) function helps companies make better decisions, anticipate threats, plan effectively in a rapidly changing market, and avoid corporate risk. But the non-traditional CI function is often undervalued in corporations, and CI leaders can often find themselves struggling for attention and resources.

Included in the research study are benchmarks for the size, structure, reporting tools and best practices that drive effectiveness in high-performing CI organizations. This study also identifies the 10 key Hallmarks of Competitive Intelligence Excellence and presents insights from interviews with veteran CI leaders on how to evolve the CI role from data gathering to providing strategic advice for decision makers.

Best Practices, LLC conducted this research project to identify best practices and innovative methods for improving the strategic role and impact of the Competitive Intelligence function within the pharmaceutical and related industries.

KEY TOPICS

  • Structure & Reporting
  • CI Evolution & Trends
  • Best Practices & Lessons Learned

SAMPLE KEY METRICS
  • Effective methods for measuring internal customers/stakeholders satisfaction
  • Steps taken to promote functional value to corporation
  • Steps taken to encourage greater usage from internal customers
  • Top 5 most effective methods for delivering insights to internal customers
  • Success factors for CI organizations
  • Steps to propel CI employees from data gatherers to strategic advisors
  • Gaining a voice in commercial issues and decisions
  • Key best practices identified by the benchmark class
  • Lessons learned for delivering value to brand teams & other key customers


SAMPLE KEY FINDINGS
  • Use of Advisory Boards to Collect CI Is Shrinking: The use of Ad Boards is down significantly from previous BPLLC studies, where as many as 90% of respondents engaged them to gather intelligence. In this study, only 52% collect intelligence from advisory boards, and only 21% find them highly effective for primary research.


STUDY METHODOLOGY


Thirty-five Competitive Intelligence leaders from 32 companies in the healthcare industry participated in this benchmarking study. Participants represented small, midcap and large biopharmaceutical and medical device companies. Seventy percent work in U.S. locations.

Industries Profiled:
Health Care; Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Distribution; Science; Technology


Companies Profiled:
Abbott Nutrition; Amgen; AstraZeneca; Ariad; Bayer; Biocon; Boehringer Ingelheim; B Braun; Covidien; Daiichi-Sankyo; Dentsply; EMD Serono; Emergent; Ethicon; Ferring; GSK; Glenmark; Janssen; Jazz; Johnson & Johnson; McKesson; Medtronic; Merck; Novo Nordisk; Pfizer; Purdue; Sanofi Pasteur; Teva; Torrent; Upsher-Smith; Waters; Wyeth Nutrition/Nestle

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.